| SC 13G/A | 2017-01-25 | BlackRock Inc. | INOTEK PHARMACEUTICALS CORP | 1,521,197 | 5.6% | EDGAR |
| SC 13G/A | 2017-01-24 | PRUDENTIAL FINANCIAL INC | INOTEK PHARMACEUTICALS CORP | 1,981,692 | 7.4% | EDGAR |
| SC 13D/A | 2017-01-06 | DEVON PARK BIOVENTURES LP | INOTEK PHARMACEUTICALS CORP | 0 | 0.0% | EDGAR |
| SC 13G | 2017-01-03 | GREAT POINT PARTNERS LLC | INOTEK PHARMACEUTICALS CORP | 1,366,500 | 5.1% | EDGAR |
| SC 13G/A | 2016-11-03 | RS INVESTMENT MANAGEMENT CO LLC | INOTEK PHARMACEUTICALS CORP | 0 | 0.0% | EDGAR |
| SC 13G | 2016-08-29 | CITADEL ADVISORS LLC | INOTEK PHARMACEUTICALS CORP | - | 6.5% | EDGAR |
| SC 13G/A | 2016-02-16 | Point72 Asset Management, L.P. | INOTEK PHARMACEUTICALS CORP | 1,148,100 | 4.3% | EDGAR |
| SC 13G | 2016-02-16 | ASTRAZENECA PLC | INOTEK PHARMACEUTICALS CORP | 1,917,906 | 7.3% | EDGAR |
| SC 13G/A | 2016-02-12 | Polygon Management Ltd. | INOTEK PHARMACEUTICALS CORP | 0 | 0.0% | EDGAR |
| SC 13G | 2016-02-12 | RHO VENTURES IV QP LP | INOTEK PHARMACEUTICALS CORP | 2,627,790 | 9.9% | EDGAR |
| SC 13G | 2016-02-12 | RS INVESTMENT MANAGEMENT CO LLC | INOTEK PHARMACEUTICALS CORP | 1,585,006 | 6.0% | EDGAR |
| SC 13G | 2016-02-09 | FRANKLIN RESOURCES INC | INOTEK PHARMACEUTICALS CORP | 1,525,800 | 5.8% | EDGAR |
| SC 13G | 2016-02-03 | JENNISON ASSOCIATES LLC | INOTEK PHARMACEUTICALS CORP | 1,919,852 | 7.3% | EDGAR |
| SC 13G | 2016-02-03 | PRUDENTIAL FINANCIAL INC | INOTEK PHARMACEUTICALS CORP | 1,919,852 | 7.3% | EDGAR |
| SC 13G | 2016-01-28 | BlackRock Inc. | INOTEK PHARMACEUTICALS CORP | 1,714,204 | 6.5% | EDGAR |
| SC 13G | 2015-08-24 | Point72 Asset Management, L.P. | INOTEK PHARMACEUTICALS CORP | 635,300 | 2.4% | EDGAR |
| SC 13G | 2015-08-03 | Polygon Management Ltd. | INOTEK PHARMACEUTICALS CORP | 1,111,111 | 6.4% | EDGAR |
| SC 13D | 2015-03-05 | DEVON PARK BIOVENTURES LP | INOTEK PHARMACEUTICALS CORP | 3,243,709 | 20.4% | EDGAR |
| SC 13D | 2015-03-05 | Care Capital III LLC | INOTEK PHARMACEUTICALS CORP | 1,521,682 | 9.6% | EDGAR |